{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:13:31Z","timestamp":1761894811477},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,11,24]],"date-time":"2008-11-24T00:00:00Z","timestamp":1227484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,11,24]],"date-time":"2008-11-24T00:00:00Z","timestamp":1227484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/bmt.2008.382","type":"journal-article","created":{"date-parts":[[2008,11,24]],"date-time":"2008-11-24T11:50:16Z","timestamp":1227527416000},"page":"701-708","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma"],"prefix":"10.1038","volume":"43","author":[{"given":"L K","family":"Hicks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Buckstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Imrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Spaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Crump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N L","family":"Berinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,24]]},"reference":[{"key":"BFbmt2008382_CR1","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.1200\/JCO.2005.03.1674","volume":"23","author":"RI Fisher","year":"2005","unstructured":"Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JM, Miller TP . New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 2005; 23: 8447\u20138452.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/sj.bmt.1701101","volume":"21","author":"CH Weaver","year":"1998","unstructured":"Weaver CH, Schwartzberg L, Rhinehart S, West J, Zhen B, West WH et al. High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1998; 21: 383\u2013389.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008382_CR3","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood.V86.8.3257.3257","volume":"86","author":"Y Bastion","year":"1995","unstructured":"Bastion Y, Brice P, Haioun C, Sonet A, Salles G, Marolleau JP et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 1995; 86: 3257\u20133262.","journal-title":"Blood"},{"key":"BFbmt2008382_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1034\/j.1600-0609.2000.90114.x","volume":"65","author":"A Berglund","year":"2000","unstructured":"Berglund A, Enblad G, Carlson K, Glimelius B, Hagberg H . Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. Eur J Haematol 2000; 65: 17\u201322.","journal-title":"Eur J Haematol"},{"key":"BFbmt2008382_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1200\/JCO.1997.15.2.445","volume":"15","author":"PJ Bierman","year":"1997","unstructured":"Bierman PJ, Vose JM, Anderson JR, Bishop MR, Kessinger A, Armitage JO . High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 445\u2013450.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR6","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1023\/A:1008399623564","volume":"11","author":"P Brice","year":"2000","unstructured":"Brice P, Simon D, Bouabdallah R, Belanger C, Haioun C, Thieblemont C et al. High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol. Ann Oncol 2000; 11: 1585\u20131590.","journal-title":"Ann Oncol"},{"key":"BFbmt2008382_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1053\/bbmt.2001.v7.pm11400952","volume":"7","author":"TM Cao","year":"2001","unstructured":"Cao TM, Horning S, Negrin RS, Hu WW, Johnston LJ, Taylor TL et al. High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience. Biol Blood Marrow Transplant 2001; 7: 294\u2013301.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008382_CR8","first-page":"157","volume":"13","author":"P Colombat","year":"1994","unstructured":"Colombat P, Donadio D, Fouillard L, Milpied N, Tilly H, Pico J et al. Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 1994; 13: 157\u2013162.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008382_CR9","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","volume":"94","author":"AS Freedman","year":"1999","unstructured":"Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood 1999; 94: 3325\u20133333.","journal-title":"Blood"},{"key":"BFbmt2008382_CR10","first-page":"350","volume":"84","author":"R Lopez","year":"1999","unstructured":"Lopez R, Martino R, Sureda A, Nomdedeu J, Briones J, Martin-Henao G et al. Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience. Haematologica 1999; 84: 350\u2013355.","journal-title":"Haematologica"},{"key":"BFbmt2008382_CR11","first-page":"171a","volume":"94","author":"A Molina","year":"1999","unstructured":"Molina A, Nademanee A, O\u2019Donnell M . Long-term follow-up and analysis of prognostic factors after high-dose therapy and peripheral blood stem cell autografting in 58 patients with a history of low grade follicular lymphoma. Blood 1999; 94: 171a.","journal-title":"Blood"},{"key":"BFbmt2008382_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/10428199909083388","volume":"34","author":"LF Verdonck","year":"1999","unstructured":"Verdonck LF . Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experience. Leuk Lymphoma 1999; 34: 129\u2013136.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2008382_CR13","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1182\/blood.V90.10.4201","volume":"90","author":"LF Verdonck","year":"1997","unstructured":"Verdonck LF, Dekker AW, Lokhorst HM, Petersen EJ, Nieuwenhuis HK . Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood 1997; 90: 4201\u20134205.","journal-title":"Blood"},{"key":"BFbmt2008382_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/sj.bmt.1702336","volume":"25","author":"MT Voso","year":"2000","unstructured":"Voso MT, Martin S, Hohaus S, Abdallah A, Schlenk RF, Ho AD et al. Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT). Bone Marrow Transplant 2000; 25: 957\u2013964.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008382_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1200\/JCO.2000.18.3.527","volume":"18","author":"J Apostolidis","year":"2000","unstructured":"Apostolidis J, Gupta RK, Grenzelias D, Johnson PW, Pappa VI, Summers KE et al. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up. J Clin Oncol 2000; 18: 527\u2013536.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR16","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","volume":"21","author":"HC Schouten","year":"2003","unstructured":"Schouten HC, Qian W, Kvaloy S, Porcellini A, Hagberg H, Johnson HE et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J Clin Oncol 2003; 21: 3918\u20133927.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1200\/JCO.1999.17.1.216","volume":"17","author":"J Apostolidis","year":"1999","unstructured":"Apostolidis J, Foran JM, Johnson PW, Norton A, Amess J, Matthews J et al. Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 1999; 17: 216\u2013221.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/10428199909167388","volume":"32","author":"CR Bachier","year":"1999","unstructured":"Bachier CR, Giles RE, Ellerson D, Hanania EG, Garcia-Sanchez F, Andreeff M et al. Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma. Leuk Lymphoma 1999; 32: 279\u2013288.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2008382_CR19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V91.1.331","volume":"91","author":"BM Leonard","year":"1998","unstructured":"Leonard BM, Hetu F, Busque L, Gyger M, Belanger R, Perreault C et al. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources. Blood 1998; 91: 331\u2013339.","journal-title":"Blood"},{"key":"BFbmt2008382_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1365-2141.2000.02244.x","volume":"110","author":"C Jacquy","year":"2000","unstructured":"Jacquy C, Soree A, Lambert F, Bosly A, Ferrant A, Andre M et al. A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells. Br J Haematol 2000; 110: 631\u2013637.","journal-title":"Br J Haematol"},{"issue":"Suppl 3","key":"BFbmt2008382_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/stem.5530130708","volume":"13","author":"M Moos","year":"1995","unstructured":"Moos M, Schulz R, Cremer F, Sucker C, Schmohl D, Dohner H et al. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies. Stem Cells 1995; 13 (Suppl 3): 42\u201351.","journal-title":"Stem Cells"},{"key":"BFbmt2008382_CR22","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1182\/blood.V83.10.3068.3068","volume":"83","author":"AB Deisseroth","year":"1994","unstructured":"Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068\u20133076.","journal-title":"Blood"},{"key":"BFbmt2008382_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","volume":"341","author":"MK Brenner","year":"1993","unstructured":"Brenner MK, Rill DR, Moen RC, Krance RA, Mirro Jr J, Anderson WF et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85\u201386.","journal-title":"Lancet"},{"key":"BFbmt2008382_CR24","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","volume":"105","author":"R Marcus","year":"2005","unstructured":"Marcus R, Imrie K, Belch A, Cunningham D, Flores E, Catalano J et al. CVP chemotherapy plus rituximab compared with CVP chemotherapy as first-line treatment for advanced follicular lymphoma. Blood 2005; 105: 1417\u20131423.","journal-title":"Blood"},{"key":"BFbmt2008382_CR25","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998; 16: 2825\u20132833.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/sj.bmt.1704102","volume":"32","author":"S Galimberti","year":"2003","unstructured":"Galimberti S, Guerrini F, Morabito F, Palumbo GA, Di Raimondo F, Papineschi F et al. Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by rituximab. Bone Marrow Transplant 2003; 32: 57\u201363.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008382_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S1470-2045(04)01646-8","volume":"5","author":"E Jacobsen","year":"2004","unstructured":"Jacobsen E, Freedman A . B-cell purging in autologous stem-cell transplantation for non-Hodgkin lymphoma. Lancet Oncol 2004; 5: 711\u2013717.","journal-title":"Lancet Oncol"},{"key":"BFbmt2008382_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/annonc\/mdh090","volume":"15","author":"K Belhadj","year":"2004","unstructured":"Belhadj K, Delfau-Larue MH, Elgnaoui T, Beaujean F, Beaumont JL, Pautas C et al. Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study. Ann Oncol 2004; 15: 504\u2013510.","journal-title":"Ann Oncol"},{"key":"BFbmt2008382_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/sj.bmt.1704551","volume":"34","author":"L Arcaini","year":"2004","unstructured":"Arcaini L, Orlandi E, Alessandrino EP, Iacona I, Brusamolino E, Bonfichi M et al. A model of in vivo purging with rituximab and high-dose AraC in follicular and mantle cell lymphoma. Bone Marrow Transplant 2004; 34: 175\u2013179.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008382_CR30","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/annonc\/mdh425","volume":"15","author":"W Brugger","year":"2004","unstructured":"Brugger W, Hirsch J, Grunebach F, Repp R, Brossart P, Vogel W et al. Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study. Ann Oncol 2004; 15: 1691\u20131698.","journal-title":"Ann Oncol"},{"key":"BFbmt2008382_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2353\/jmoldx.2006.050050","volume":"8","author":"N Pennell","year":"2006","unstructured":"Pennell N, Woods A, Reis M, Buckstein R, Spaner D, Imrie K et al. Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction. J Mol Diagn 2006; 8: 40\u201350.","journal-title":"J Mol Diagn"},{"key":"BFbmt2008382_CR32","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/sj.leu.2401559","volume":"13","author":"P Corradini","year":"1999","unstructured":"Corradini P, Ladetto M, Pileri A, Tarella C . Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas: a critical reappraisal of molecular strategies. Leukemia 1999; 13: 1691\u20131695.","journal-title":"Leukemia"},{"key":"BFbmt2008382_CR33","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2004.10.054","volume":"22","author":"P Corradini","year":"2004","unstructured":"Corradini P, Ladetto M, Zallio F, Astolfi M, Rizzo E, Sametti S et al. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes. J Clin Oncol 2004; 22: 1460\u20131468.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR34","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/sj.leu.2401242","volume":"12","author":"M Moos","year":"1998","unstructured":"Moos M, Schulz R, Martin S, Benner A, Haas R . The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma. Leukemia 1998; 12: 1971\u20131976.","journal-title":"Leukemia"},{"key":"BFbmt2008382_CR35","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood.V81.12.3449.3449","volume":"81","author":"JG Gribben","year":"1993","unstructured":"Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449\u20133457.","journal-title":"Blood"},{"key":"BFbmt2008382_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I","volume":"43","author":"SE Jones","year":"1979","unstructured":"Jones SE, Grozea PN, Metz EN, Haut A, Stephens RL, Morrison FS et al. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study. Cancer 1979; 43: 417\u2013425.","journal-title":"Cancer"},{"key":"BFbmt2008382_CR37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","volume":"1","author":"WS Velasquez","year":"1988","unstructured":"Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 1988; 1: 117\u2013122.","journal-title":"Blood"},{"key":"BFbmt2008382_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1023\/A:1008294725992","volume":"8","author":"C Girouard","year":"1997","unstructured":"Girouard C, Dufresne J, Imrie K, Stewart AK, Brandwein J, Prince HM et al. Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation. Ann Oncol 1997; 8: 675\u2013680.","journal-title":"Ann Oncol"},{"key":"BFbmt2008382_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.7326\/0003-4819-104-2-163","volume":"104","author":"S Jagannath","year":"1986","unstructured":"Jagannath S, Dicke KA, Armitage JO, Cabanillas FF, Horwitz LJ, Vellekoop L et al. High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease. Ann Intern Med 1986; 104: 163\u2013168.","journal-title":"Ann Intern Med"},{"key":"BFbmt2008382_CR40","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2008382_CR42","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-Celigny","year":"2004","unstructured":"Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258\u20131265.","journal-title":"Blood"},{"key":"BFbmt2008382_CR43","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1084\/jem.161.6.1483","volume":"161","author":"KA Ault","year":"1985","unstructured":"Ault KA, Antin JH, Ginsburg D, Orkin SH, Rappeport JM, Keohan ML et al. Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med 1985; 161: 1483\u20131502.","journal-title":"J Exp Med"},{"key":"BFbmt2008382_CR44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/blood.V72.2.672.672","volume":"72","author":"S Kiesel","year":"1988","unstructured":"Kiesel S, Pezzutto A, Moldenhauer G, Haas R, Korbling M, Hunstein W et al. B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation. Blood 1988; 72: 672\u2013678.","journal-title":"Blood"},{"key":"BFbmt2008382_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.bmt.1704742","volume":"35","author":"SH Lim","year":"2005","unstructured":"Lim SH, Zhang Y, Wang Z, Esler WV, Beggs D, Pruitt B et al. Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia. Bone Marrow Transplant 2005; 35: 207\u2013208.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008382_CR46","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bmt.1703925","volume":"31","author":"G Hess","year":"2003","unstructured":"Hess G, Flohr T, Huber C, Kolbe K, Derigs HG, Fischer T . Safety and feasibility of CHOP\/rituximab induction treatment followed by high-dose chemo\/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma. Bone Marrow Transplant 2003; 31: 775\u2013782.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008382_CR47","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/blood-2003-04-1257","volume":"103","author":"SM Horwitz","year":"2004","unstructured":"Horwitz SM, Negrin RS, Blume KG, Breslin S, Stuart MJ, Stockerl-Goldstein KE et al. Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood 2004; 103: 777\u2013783.","journal-title":"Blood"},{"key":"BFbmt2008382_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.bmt.1705463","volume":"38","author":"J Shortt","year":"2006","unstructured":"Shortt J, Spencer A . Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 2006; 38: 433\u2013436.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008382_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/10428190701742506","volume":"49","author":"SH Lim","year":"2008","unstructured":"Lim SH, Esler WV, Zhang Y, Zhang J, Periman PO, Burris C et al. B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period. Leuk Lymphoma 2008; 49: 152\u2013153.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2008382_CR50","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood.V100.6.2257","volume":"100","author":"LE Van Der Kolk","year":"2002","unstructured":"Van Der Kolk LE, Baars JW, Prins MH, Van Oers MH . Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 2002; 100: 2257\u20132259.","journal-title":"Blood"},{"key":"BFbmt2008382_CR51","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1182\/blood-2002-02-0621","volume":"100","author":"M Ladetto","year":"2002","unstructured":"Ladetto M, Corradini P, Vallet S, Benedetti F, Vitolo U, Martelli M et al. High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood 2002; 100: 1559\u20131565.","journal-title":"Blood"},{"key":"BFbmt2008382_CR52","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1182\/blood.V99.4.1486","volume":"99","author":"SL Goldberg","year":"2002","unstructured":"Goldberg SL, Pecora AL, Alter RS, Kroll MS, Rowley SD, Waintraub SE et al. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 2002; 99: 1486\u20131488.","journal-title":"Blood"},{"key":"BFbmt2008382_CR53","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1200\/JCO.2003.08.054","volume":"21","author":"PJ Bierman","year":"2003","unstructured":"Bierman PJ, Sweetenham JW, Loberiza Jr FR, Taghipour G, Lazarus HM, Rizzo JD et al. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation\u2013\u2013The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. J Clin Oncol 2003; 21: 3744\u20133753.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR54","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1182\/blood-2004-04-1323","volume":"104","author":"R Forstpointner","year":"2004","unstructured":"Forstpointner R, Dreyling M, Repp R, Hermann S, Hanel A, Metzner B et al. The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 2004; 104: 3064\u20133071.","journal-title":"Blood"},{"key":"BFbmt2008382_CR55","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"W Hiddemann","year":"2005","unstructured":"Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 2005; 106: 3725\u20133732.","journal-title":"Blood"},{"key":"BFbmt2008382_CR56","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1182\/blood-2006-05-021113","volume":"108","author":"MH van Oers","year":"2006","unstructured":"van Oers MH, Klasa R, Marcus RE, Wolf M, Kimby E, Gascoyne RD et al. Rituximab maintenance improves clinical outcome of relapsed\/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial. Blood 2006; 108: 3295\u20133301.","journal-title":"Blood"},{"key":"BFbmt2008382_CR57","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1200\/JCO.2000.18.17.3135","volume":"18","author":"TA Davis","year":"2000","unstructured":"Davis TA, Grillo-Lopez AJ, White CA, McLaughlin P, Czuczman MS, Link BK et al. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment. J Clin Oncol 2000; 18: 3135\u20133143.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR58","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1200\/JCO.2005.12.191","volume":"23","author":"JD Hainsworth","year":"2005","unstructured":"Hainsworth JD, Litchy S, Shaffer DW, Lackey VL, Grimaldi M, Greco FA . Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma\u2013\u2013a randomized phase II trial of the Minnie Pearl Cancer Research Network. J Clin Oncol 2005; 23: 1088\u20131095.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008382_CR59","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3324\/haematol.11288","volume":"92","author":"E Carlotti","year":"2007","unstructured":"Carlotti E, Palumbo GA, Oldani E, Tibullo D, Salmoiraghi S, Rossi A et al. FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab. Haematologica 2007; 92: 1127\u20131130.","journal-title":"Haematologica"},{"key":"BFbmt2008382_CR60","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1056\/NEJM200306263482619","volume":"348","author":"C Burton","year":"2003","unstructured":"Burton C, Kaczmarski R, Jan-Mohamed R . Interstitial pneumonitis related to rituximab therapy. N Engl J Med 2003; 348: 2690\u20132691; discussion 2690\u20132691.","journal-title":"N Engl J Med"},{"key":"BFbmt2008382_CR61","first-page":"361","volume":"89","author":"R Cairoli","year":"2004","unstructured":"Cairoli R, Grillo G, Tedeschi A, D\u2019Avanzo G, Marenco P, Morra E . High incidence of neutropenia in patients treated with rituximab after autologous stem cell transplantation. Haematologica 2004; 89: 361\u2013363.","journal-title":"Haematologica"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008382.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008382","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008382.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:25:09Z","timestamp":1648034709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,24]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFbmt2008382"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.382","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,24]]},"assertion":[{"value":"11 January 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}